• SENSEX 73,123.83
    -125.56 (--0.17%)
  • BANKNIFTY 54,287.35
    -638.35 (--1.16%)
  • SBI
    950.75 900.80(%)
  • Tonbo Imaging
    1,209.85 1,209.85(%)
  • Cyient
    1,268.00 1,268.00(%)
  • NSE
    1,640.25 1,640.25(%)
  • Bonfiglioli Tran
    527.40 527.40(%)
  • IndusInd Bank
    831.35 750.45(%)
  • Eternal
    317.50 344.75(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 940.00(%)
  • Swiggy
    174.90 174.90(%)
  • Persistent Systems
    5,688.80 4,242.65(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,003.65(%)
  • PC Jeweller
    17.08 7.45(%)
  • Bharat Forge
    1,680.45 1,265.00(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Themis Medicare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Themis
  • BSE Code : 4895.0
  • ISIN : INE083B01024
90.74 -4 (-4.07%)
  • As on 24 Oct 2026 (EOD)
  • Today’s Low

    88.86
  • Today’s High

    94.87
  • Open

    94.87
  • Perv Close

    94.59
  • 52W Low

    64.95
  • 52W High

    140.60

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    835.72

  • Div & Yield %

    0.55

  • Book Value(₹)

    29.14

  • Debt-Equity Ratio

    -4.07

  • AGM Date

    23-Oct-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.29

  • Mar.Cap (₹Cr.)

    835.72

  • RONW (%)

    13.39

  • ROCE (%)

    14.99

Score Board

  • Equity (₹ in Cr.)

    9.21

  • BV (₹)

    29.10

  • Sales( ₹ in Cr.)

    342.24

  • NP (in Cr.)

    -12.15

  • NP Var(%)

    -151.0

  • Div%

    50.0

  • CPS (₹)

    -0.20

  • EPS (₹)

    -1.30

  • Traded Value (₹ in Lakhs)

    832.12

  • 52 Week High

    140.60

  • 52 Week Low

    64.95

  • Price BSE

    90.0

  • Price NSE

    91.00

  • Market Capital( in Cr.)

    832.12

  • P/C Ratio

    -452.60

  • P/E Ratio

    -68.20

  • Price Vs.BV

    -1.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 342.24 405.51 381.76 354.32 394.61 230.67
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 342.24 405.51 381.76 354.32 394.61 230.67
Other Income 9.36 4.67 4.76 11.50 6.54 3.62
Stock Adjustments -9.17 17.98 1.57 7.79 -3.06 1.27
Total Income 342.43 428.16 388.09 373.61 398.09 235.56
EXPENDITURE :            
Raw Materials 120.31 149.98 138.28 126.16 145.08 79.48
Power and Fuel Cost 12.20 11.81 13.46 11.83 12.18 11.32
Employee Cost 93.52 96.38 82.41 66.15 51.97 39.99
Other Manufacturing Expenses 29.80 29.02 27.52 25.98 32.96 16.11
Selling and Administration Expenses 59.11 60.77 51.84 44.15 34.85 21.00
Miscellaneous Expenses 19.90 26.48 18.29 20.39 18.86 14.16
Employee Benefit Expenses 93.52 96.38 82.41 66.15 51.97 39.99
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 334.83 374.44 331.79 294.66 295.90 182.06
Operating Profit 7.61 53.73 56.29 78.96 102.19 53.50
Interest 10.69 10.04 9.38 9.56 8.77 12.71
Gross Profit -3.08 43.69 46.91 69.40 93.42 40.79
Depreciation 10.32 9.93 12.25 10.49 9.48 8.55
Profit Before Tax -13.40 33.76 34.66 58.91 83.94 32.24
Current Tax 0.00 8.30 9.22 15.00 16.75 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.78 1.54 0.70 0.61 5.63 5.63
Reported Net Profit -14.19 23.92 24.75 43.29 61.56 26.62
Extraordinary Items -2.03 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -12.16 23.92 24.75 43.29 61.56 26.62
Adjustment below Net Profit -0.74 -0.31 -0.74 -0.43 -0.32 1.46
P & L Balance brought forward 174.91 155.50 135.62 96.79 38.98 11.98
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.20 4.20 4.14 4.03 3.43 1.09
P & L Balance carried down 155.79 174.91 155.50 135.62 96.79 38.98
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 50.00 50.00 50.00 50.00 43.00
Dividend Per Share(Rs) 0.50 0.50 0.50 5.00 5.00 4.30
Earnings Per Share-Unit Curr -1.54 2.60 2.69 47.04 66.91 28.97
Earnings Per Share(Adj)-Unit Curr -1.54 2.60 2.69 4.70 6.69 2.90
Book Value 29.14 31.22 29.11 269.54 227.50 164.59
Book Value(Adj)-Unit Curr 29.14 31.22 29.11 26.96 22.75 16.46

Shareholding Pattern

  • Promoter Group

    67.11%

  • Public Share Holding

    32.89%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 8,843,080 9.60 8,843,080 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 8,843,080 9.60 8,843,080 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 24,429,460 26.52 24,429,460 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 28,531,450 30.98 28,531,450 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 52,960,910 57.50 52,960,910 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 10,000 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,377 0.01 9,377 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,133 0.00 1,133 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 450 0.00 450 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,960 0.02 10,960 6
2] Non Institution
Bodies Corporate 3,833,547 4.16 3,832,547 125
Clearing Members 71,755 0.08 71,755 12
Directors of their Relatives 72,500 0.08 72,500 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,820,418 3.06 2,644,418 309
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,523,026 1.65 1,521,986 575
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,290,741 6.83 6,290,741 9
Individuals holding nominal share capital up to Rs. 1 lakh 15,127,973 16.43 14,526,212 19,063
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 366,840 0.40 366,840 2
Sub Total 30,275,170 32.87 29,494,369 20,109
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 92,100,120 100.00 91,309,319 20,126

Company Background

Themis Medicare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Themis Medicare Ltd
  • BSE Code : 4895.0
  • ISIN : INE083B01024
  • Incorporation Year

    1969

  • Registered Office

    Plot No 69 A GIDC Indl Estate
    Vapi, Valsad,
    Gujarat-396195

  • Telephone

    91-260-2421675

  • FAX

    91-260-2430219

  • Chairman

    Dinesh S Patel

  • Managing Director

    Sachin D Patel

  • Company Secretary

    Suresh Savaliya

  • Auditor

    Krishaan & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Themis Medicare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Themis Medicare 90.35 351.60 342.24 27.80 -0.15
Abbott India 25,004.30 7,217.19 6,929.05 32.91 43.78
Astrazeneca Phar 5,988.15 2,304.07 2,275.58 88.26 27.86
Glaxosmi. Pharma 2,404.80 3,932.76 3,790.20 38.42 58.17
Novartis India 1,834.75 393.10 354.33 46.33 15.94
Cipla 1,337.00 20,102.60 18,979.95 35.14 13.88
Bliss GVS Pharma 628.50 773.53 729.81 58.41 12.51
Amrutanjan Healt 487.65 520.13 502.55 26.12 24.16
Fermenta Biotec. 454.90 474.15 450.25 21.24 18.77
Guj. Themis Bio. 327.25 168.25 165.82 87.50 18.05
Ambalal Sarabhai 34.60 19.52 3.94 64.07 6.77